YBX1 and neoplasm: Research also indicates that phosphorylated YBX1 can enhance the expression of Chemokine Ligand 5 (CCL5), a cytokine involved in recruiting immune cells to sites of inflammation, and PD-L1, which plays a key role in tumor immune evasion by inhibiting T-cell activity, by binding to their promoter regions [100,101,102].